2021
DOI: 10.1177/03000605211033222
|View full text |Cite
|
Sign up to set email alerts
|

Ultra-high-risk choriocarcinoma with atraumatic splenic rupture: a rare case report

Abstract: Choriocarcinoma is a malignant tumor associated with early vascular invasion and a high mortality. Ultra-high-risk choriocarcinoma, which was proposed in the International Federation of Gynecology and Obstetrics cancer report of 2018, has a higher risk of treatment failure and a worse prognosis than choriocarcinoma. We report a rare case of a 39-year-old female patient with ultra-high-risk choriocarcinoma (stage IV:20) with hemorrhage secondary to atraumatic splenic rupture as the initial sign. A satisfactory … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…Surgical resection is reasonable when it is possible. Although there is such pathological type associated with hemorrhage as choriocarcinoma with early vascular invasion [26], intra-tumoral hemorrhage does not frequently occur to UCP with osteoclast-like giant cells. In our case, intra-abdominal hemorrhage was caused by the rupture of the distension tumor with intra-tumoral hemorrhage due to the invasion of the tumor cells to splenic vein under anticoagulation therapy.…”
Section: Discussionmentioning
confidence: 98%
“…Surgical resection is reasonable when it is possible. Although there is such pathological type associated with hemorrhage as choriocarcinoma with early vascular invasion [26], intra-tumoral hemorrhage does not frequently occur to UCP with osteoclast-like giant cells. In our case, intra-abdominal hemorrhage was caused by the rupture of the distension tumor with intra-tumoral hemorrhage due to the invasion of the tumor cells to splenic vein under anticoagulation therapy.…”
Section: Discussionmentioning
confidence: 98%